Literature DB >> 1129309

Effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) on Friend leukemia virus infections in mice.

R W Sidwell, L B Allen, J H Huffman, J T Witkowski, L N Sinon.   

Abstract

Ribavirin, when administered intraperitoneally to mice infected with Friend leukemia virus, significantly inhibited development of the disease as determined by inhibition of virus-induced splenomegaly and viable virus titers in the spleen and plasma of the infected animals. The drug was effective whether administered ip in multiple daily treatments, treatments every three days, or single injection. Greatest efficacy was seen when therapy began early in the infection, presumably while the virus was in its eclipse phase.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1129309     DOI: 10.3181/00379727-148-38647

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  5 in total

1.  Visna virus as an in vitro model for human immunodeficiency virus and inhibition by ribavirin, phosphonoformate, and 2',3'-dideoxynucleosides.

Authors:  K B Frank; P A McKernan; R A Smith; D F Smee
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

Review 2.  Ribavirin: a clinical overview.

Authors:  H Fernandez; G Banks; R Smith
Journal:  Eur J Epidemiol       Date:  1986-03       Impact factor: 8.082

3.  Effects of ribavirin on the development of the Friend leukemia.

Authors:  U Opitz; H J Seidel; G Streissle
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

4.  Effect of ribavirin on Rous sarcoma virus transformation.

Authors:  F J Jenkins; Y C Chen
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

5.  In vitro and in vivo Phlebovirus inhibition by ribavirin.

Authors:  R W Sidwell; J H Huffman; B B Barnett; D Y Pifat
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.